Crucell's Quinvaxem Faces Further Controversy

News: A six-month-old baby died in the week ended March 21, reportedly after being administered Quinvaxem, a vaccine produced by Dutch biotech firm Crucell. Since late 2012 the drug has been linked to 11 other infant deaths. Despite a temporary ban by the health ministry in May 2012 over connections with nine deaths between November 2012 and March 2013, the World Health Organization (WHO) lifted the ban, declaring the vaccine safe. The drug is a combination vaccine that protects against diphtheria, tetanus, pertussis (whooping cough), hepatitis B and Haemophilus influenzae Type B infections

This article is tagged to:
Related sectors of this article: Pharmaceuticals & Healthcare, Regulatory - Pharmaceuticals & Healthcare
Geography: Vietnam

Enter your details to read the full article

By submitting this form you are acknowledging that you have read and understood our Privacy Policy.